Sun Pharma gets USFDA nod for Prometh syrup

19 Mar 2010 Evaluate

Drug major Sun Pharma has received approval from the US health regulator for generic version of anti-allergic product Prometh syrup. The United States Food and Drug Administration (FDA) has granted an approval to the company's subsidiary for the syrup.

 

The company's product--Promethazine Hydrochloride and Codeine Phosphate Oral Syrup--is bioequivalent to Prometh. It has annual sales of about $16 million in the US. The medicine is used to treat symptoms caused by common cold, flu, allergies or other breathing problems.

crackcrack

Sun Pharma Inds. Share Price

1786.85 -17.65 (-0.98%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...